Recent developments in the identification and biosynthesis of antitumor drugs derived from microorganisms
Secondary metabolites in microorganisms represent a resource for drug discovery and development. In particular, microbial-derived antitumor agents are in clinical use worldwide. Herein, we provide an overview of the development of classical antitumor drugs derived from microorganisms. Currently used...
| Hoofdauteurs: | , , |
|---|---|
| Formaat: | Artikel |
| Taal: | English |
| Gepubliceerd in: |
Elsevier
2022-12-01
|
| Reeks: | Engineering Microbiology |
| Onderwerpen: | |
| Online toegang: | http://www.sciencedirect.com/science/article/pii/S2667370322000388 |